The Competitive Readiness and Strategy Lead will serve as the primary owner of portfolio-level competitive strategy across Pfizer’s global obesity franchise, owning the translation of competitive intelligence into prioritized strategic insights for Pfizer’s obesity portfolio and together with Commercial product lead(s), ensuring sustained long-term differentiation across the portfolio. This role is accountable for translating external competitive insights across markets into clear strategic recommendations for both pipeline portfolio development and on-market commercial positioning. As Pfizer’s obesity portfolio progresses through late-stage development and early commercialization, this position plays a critical role in guiding in guiding cross-functional strategic decision-making within a rapidly evolving competitive landscape to enable optimal patient and business outcomes. The emphasis of the role is not simply on information synthesis or dissemination, but disciplined interpretation to connect the dots more broadly into clear implications for category strategy, portfolio choices, and asset-level implications. Operating as a highly embedded member of the Obesity Global Commercial Development team, the role requires an experienced leader who operates with a high degree of independence and generates timely second and third-order insights for the business. This role is expected to partner closely with CI and pull through their intelligence gathering into business implications. The role requires a “competitive business owner” mindset, who can converse across R&D, clinical development, BD, and commercial strategy and move fluidly between asset-level depth and portfolio-level perspective.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level